Fiche centre
Leiden University Medical Center
Leiden — Netherlands
Essais liés11clinical trials
VilleLeidenlocalisation
PaysNetherlandslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06392386
Essais cliniques associés
11| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| PreciseOnco — Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance | Cancer | À vérifier | NCT07636148 | PreciseOnco — Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance | RECRUITING |
| BBP-418 (ribitol) | Myopathies | Phase 3 | NCT05775848 | Fortify — Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) | ACTIVE_NOT_RECRUITING |
| Efgartigimod PH20 SC | Myasthénie | Phase 2/3 | NCT06392386 | ADAPT Jr SC — A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis | RECRUITING |
| K+ in CKD — Potassium Supplementation in CKD | Hypertension | Non applicable | NCT03253172 | K+ in CKD — Potassium Supplementation in CKD | ACTIVE_NOT_RECRUITING |
| CAPTURE - MG — Capturing Key MG-symptoms Using Smartphone Recordings. | Myasthénie | À vérifier | NCT06743490 | CAPTURE - MG — Capturing Key MG-symptoms Using Smartphone Recordings. | RECRUITING |
| FIT to ACT-MG — Interventions Against Fatigue in Patients With Myasthenia Gravis | Myasthénie | Non applicable | NCT06659627 | FIT to ACT-MG — Interventions Against Fatigue in Patients With Myasthenia Gravis | ACTIVE_NOT_RECRUITING |
| Nipocalimab | Myasthénie | Phase 2/3 | NCT05265273 | A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis | RECRUITING |
| Efgartigimod IV | Myasthénie | Phase 3 | NCT06298552 | ADAPT SERON — A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis | ACTIVE_NOT_RECRUITING |
| Pyridostigmine | Myasthénie | Phase 3 | NCT05919407 | IMPACT-MG — Pyridostigmine and Amifampridine for Myasthenia Gravis | UNKNOWN |
| Drisapersen | Myopathies | À vérifier | NCT02636686 | Extension Study of Drisapersen in DMD Subjects | NO_LONGER_AVAILABLE |
| BMN 044 IV 6 mg/kg | Myopathies | Phase 2 | NCT02958202 | Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD) | TERMINATED |